Results for "Specialty Pharmaceutical Distribution Facts, Figures, and Trends"
HDA Urges FDA To Adopt Alternatives to Broad DSCSA Enforcement Discretion
The Healthcare Distribution Alliance (HDA) urged the Food and Drug Administration (FDA) to avoid delaying certain requirements for manufacturers and repackagers to comply with the November 27, 2023, Drug Supply Chain Security Act (DSCSA) deadline, in public comments submitted to the agency.
HDA Statement on Expiration of the COVID-19 Public Health Emergency
The Healthcare Distribution Alliance (HDA) released a statement from President and CEO Chester “Chip” Davis, Jr., on the expiration of the federal Public Health Emergency (PHE) for COVID-19.
Pennsylvania Healthcare Community Launches Effort to Improve Supply Chain Integration and Collaboration
The Pennsylvania Healthcare Supply Chain Leadership Alliance (PA-HSCLA) convened the Commonwealth’s healthcare and provider industry today to launch a collective effort aimed at creating a more resilient healthcare product supply chain in the Commonwealth.
HDA Names New Federal Government Affairs, Communications Appointments
The Healthcare Distribution Alliance (HDA) announced new appointments to its Government Affairs and Communications teams.
Securing the Pharmaceutical Supply Chain Against Scammers
The global supply chain continues to face scrutiny, with port backups and product shortages grabbing headlines. However, as Chuck Forsaith, Vice President and Founder of HDA’s Pharmaceutical Cargo Security Coalition (PCSC), shared in a recent episode of the Pharmacy Crossroads podcast, there is another supply chain risk impacting trading partners throughout the healthcare distribution industry — which HDA’s PCSC has been diligently tracking and working to combat. Pharmacy Crossroads, hosted by pharmacy industry veteran Bruce Kneeland, provides an insider voice for the community pharmacy industry and is a member of the Pharmacy Podcast Network.